logo-loader
viewHepQuant LLC

HepQuant CEO sees 'huge, unmet need' in the liver space

HepQuant LLC CEO Greg Everson joined Proactive at the Biotech Showcase 2020 in San Francisco. HepQuant is a privately-held, early-stage medical diagnostics company who's technology, licensed from the University of Colorado Denver, assesses the liver function of patients with chronic liver disease.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Ceres Power eyes expansion following new Bosch deal

This month German engineering firm Bosch increased its stake in Ceres Power Holdings (LON:CWR) to around 18% from 4% following a share subscription, netting Ceres £38mln. It was Bosch that approached Ceres too, pinpointing Ceres steel fuel cell technology as potentially the best in the...

3 hours, 32 minutes ago

2 min read